Mode
Text Size
Log in / Sign up

lorcaserin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of lorcaserin

10 trials tracked of lorcaserin: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 263 citations.

10Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 2 Phase 2 4 Phase 1 2 Other / NA 1
  1. Phase 4 A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors Completed · 263 cited
  2. Phase 3 Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management Completed · 13 cited
  3. Phase 3 Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder Completed
  4. Phase 2 Lorcaserin for Preventing Weight Gain Among Smokers Completed
  5. Phase 2 Combination Nicotine Patch / Lorcaserin for Smoking Cessation Completed
  6. Phase 2 Effect of Lorcaserin on Cannabis Withdrawal and Self-administration Completed
Show 4 more trials
  1. Phase 2 Lorcaserin in the Treatment of Cocaine Use Disorder Completed
  2. Phase 1 Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder Completed
  3. Phase 1 Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder Completed
  4. N/A Lifestyle Modification and Lorcaserin for Weight Loss Maintenance Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.